|1.||Victor, Bruno L: 1 article (04/2015)|
|2.||Lousa, Diana: 1 article (04/2015)|
|3.||Soares, Cláudio M: 1 article (04/2015)|
|4.||Antunes, Jorge M: 1 article (04/2015)|
|5.||Stotland, Patricia: 1 article (01/2015)|
|6.||Carballo, Dolores: 1 article (01/2015)|
|7.||Normand, Patrick: 1 article (01/2015)|
|8.||Triest, Myriam: 1 article (01/2015)|
|9.||Piché, Claude: 1 article (01/2015)|
|10.||Silo, Sherwin: 1 article (01/2015)|
|1.||Human Influenza (Influenza)
04/27/2015 - "To shed light into this matter, we performed molecular dynamics (MD) simulations of the influenza FP in different environments (water, dodecylphosphocholine (DPC) micelles, and a dimyristoylphosphatidylcholine (DMPC) membrane). "
03/09/2011 - "The fusion domain of the influenza coat protein hemagglutinin HA2, bound to dodecyl phosphocholine micelles, was recently shown to adopt a structure consisting of two antiparallel α-helices, packed in an exceptionally tight hairpin configuration. "
12/16/2005 - "Molecular dynamics simulations of the influenza hemagglutinin fusion peptide in two differently sized dodecylphosphocholine micelles and a palmitoyl oleoyl phosphatidylcholine bilayer were generated to analyze the influence of the environment. "
03/30/2011 - "Specific binding of adamantane drugs and direction of their polar amines in the pore of the influenza M2 transmembrane domain in lipid bilayers and dodecylphosphocholine micelles determined by NMR spectroscopy."
07/15/2007 - "(19)F NMR probes were used to follow interactions between ligands in the aminoadamantane series, amantadine (Am) 1 and 3-F-Am 2, and the 5-F-Trp20 transmembrane fragment of the influenza A M2 proton channel (F-M2TM 3) in dodecylphosphocholine micelles over the pH range 5-8. Above pH 7, when the peptide adopts a tetrameric state that is able to bind channel blocking ligands, (19)F-Trp signals from both the free and bound states of the M2TM tetramer are resolved. "
08/01/2004 - "Circular dichroism and 2D homonuclear NMR experiments demonstrate that this tumor-specific HKP adopts a left-handed amphipathic helix in association with dodecylphosphorylcholine micelles in a parallel orientation to the lipid-water interface with the homing domain remaining exposed to solvent. "
09/01/1996 - "Iodine-125-12-[m-iodophenyl]-dodecylphosphocholine (NM-324) has been shown to accumulate in a variety of animal tumor models. "
10/01/1992 - "12-(m[125I]iodophenyl)dodecyl phosphocholine (NM-324) and hexadecyl-2-[N,N-dimethyl-N-(m[125I]iodobenzyl)-ammonium] ethyl phosphate (NM-326) demonstrated the ability of such compounds to localize in and thereby visualize the Walker 256 tumor in rats. "
08/31/1998 - "Dodecylphosphocholine, hexadecylphosphocholine (HPC) and (octadecyl-[2-(N-methylpiperidino)-ethyl]phosphate exhibited a mild clastogenicity at equimolar high doses on murine bone marrow cells in vivo, which is unusual for the majority of classical DNA-interacting anti-cancer drugs. "
11/01/1996 - "The conformational properties of three Tyr-Tic-NH-R dipeptide analogs [where R = (CH2)2-Ph, (CH2)3-Ph or (CH2)2-cHx; Ph = phenyl; cHx = cyclohexyl and Tic = tetrahydroisoquinoline-3-carboxylic acid] have been investigated in purely aqueous solution and in the presence of fully deuterated dodecylphosphocholine micelles. "
|4.||Hypoglycemia (Reactive Hypoglycemia)
|5.||Dehydration (Water Stress)
|5.||Lipid Bilayers (Lipid Bilayer)
|10.||DNA (Deoxyribonucleic Acid)